EA201190282A1 - Фармацевтическая композиция, содержащая тамсулозин - Google Patents

Фармацевтическая композиция, содержащая тамсулозин

Info

Publication number
EA201190282A1
EA201190282A1 EA201190282A EA201190282A EA201190282A1 EA 201190282 A1 EA201190282 A1 EA 201190282A1 EA 201190282 A EA201190282 A EA 201190282A EA 201190282 A EA201190282 A EA 201190282A EA 201190282 A1 EA201190282 A1 EA 201190282A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
tamsulus
composition containing
composition
tamsulosin
Prior art date
Application number
EA201190282A
Other languages
English (en)
Other versions
EA024365B1 (ru
Inventor
Грегор Седмак
Марко Стефаниц
Original Assignee
Крка, Товарна Здравил, Д.Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09161448A external-priority patent/EP2255793A1/en
Application filed by Крка, Товарна Здравил, Д.Д., Ново Место filed Critical Крка, Товарна Здравил, Д.Д., Ново Место
Publication of EA201190282A1 publication Critical patent/EA201190282A1/ru
Publication of EA024365B1 publication Critical patent/EA024365B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к фармацевтической композиции, содержащей тамсулозин или его фармацевтически приемлемую соль или сольват, в твердой лекарственной форме и к способу получения такой композиции.
EA201190282A 2009-05-28 2010-05-26 Фармацевтическая композиция, содержащая тамсулозин, и способ ее получения EA024365B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09161448A EP2255793A1 (en) 2009-05-28 2009-05-28 Pharmaceutical composition comprising tamsulosin
EP09011556 2009-09-09
PCT/EP2010/003202 WO2010136193A1 (en) 2009-05-28 2010-05-26 Pharmaceutical composition comprising tamsulosin

Publications (2)

Publication Number Publication Date
EA201190282A1 true EA201190282A1 (ru) 2012-04-30
EA024365B1 EA024365B1 (ru) 2016-09-30

Family

ID=42364447

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190282A EA024365B1 (ru) 2009-05-28 2010-05-26 Фармацевтическая композиция, содержащая тамсулозин, и способ ее получения

Country Status (3)

Country Link
EP (1) EP2435029B1 (ru)
EA (1) EA024365B1 (ru)
WO (1) WO2010136193A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014013175B1 (pt) * 2011-12-02 2022-08-09 Pegasus Laboratories, Inc Processo para preparar comprimidos de composição de liberação prolongada
CN102579392A (zh) * 2012-03-30 2012-07-18 重庆科瑞制药(集团)有限公司 一种含有盐酸坦索罗辛的缓释制剂及其制备方法
CN105012261B (zh) * 2015-08-21 2018-03-06 德州德药制药有限公司 一种咖啡酸片及其制备方法
WO2021220133A1 (en) * 2020-04-27 2021-11-04 Zim Laboratories Limited Novel multiparticulate pharmaceutical composition of tamsulosin and solifenacin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
EP2042169A1 (en) * 2007-09-26 2009-04-01 LEK Pharmaceuticals D.D. Controlled release tamsulosin hydrochloride tablets and a process of making them

Also Published As

Publication number Publication date
EP2435029B1 (en) 2016-12-14
EA024365B1 (ru) 2016-09-30
EP2435029A1 (en) 2012-04-04
WO2010136193A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
EA201190319A1 (ru) Твердая фармацевтическая композиция, содержащая ривароксабан
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
CL2013003406A1 (es) Compuestos derivados de dolastatina unidos a aminoacidos no naturales; procedimiento de preparacion; composiciones farmaceuticas, útiles en el tratamiento del cancer de mamas.
MY187047A (en) Selective pyy compounds and uses thereof
CO6801720A2 (es) Método para producir preparados farmacéuticos con contenido de ibp
MX348823B (es) Formulaciones estables de linaclotida.
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
IN2014DN10670A (ru)
DK2442790T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser
EA033374B1 (ru) Твердые фармацевтические композиции, содержащие энзалутамид, и способ лечения
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
EA201390662A1 (ru) Фармацевтическая композиция, содержащая дутастерид
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
IT1404931B1 (it) Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
EA033171B1 (ru) Полутвёрдая фармацевтическая композиция на водной основе, содержащая тапентадол
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
EA201490760A1 (ru) R(+)-n-метилпропаргиламиноиндан
EA201490756A1 (ru) Разагилина цитрамид
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
EA201400444A1 (ru) Производные 2-оксопиперидинила
EA201492029A1 (ru) N-этил-4-гидроксил-1-метил-5-(метил(2,3,4,5,6-пентагидроксигексил)амино)-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид
EA201591150A1 (ru) Твердая единая форма с высоким содержанием фексофенадина и способ ее получения

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU